The economic burden of malaria inpatients and its determinants during China's elimination stage

BackgroundMalaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world.ObjectiveThis study aimed to investigate China's malaria hospitalization costs and explore its determinants.MethodsStratified multistage...

Full description

Bibliographic Details
Main Authors: Fangfei Chen, Xiaoyu Chen, Peng Gu, Xiaodong Sang, Ruijun Wu, Miaomiao Tian, Yisheng Ye, Chengxu Long, Ghose Bishwajit, Lu Ji, Da Feng, Lei Yang, Shangfeng Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.994529/full
_version_ 1811246385110974464
author Fangfei Chen
Xiaoyu Chen
Peng Gu
Xiaodong Sang
Ruijun Wu
Miaomiao Tian
Yisheng Ye
Chengxu Long
Ghose Bishwajit
Lu Ji
Da Feng
Lei Yang
Shangfeng Tang
author_facet Fangfei Chen
Xiaoyu Chen
Peng Gu
Xiaodong Sang
Ruijun Wu
Miaomiao Tian
Yisheng Ye
Chengxu Long
Ghose Bishwajit
Lu Ji
Da Feng
Lei Yang
Shangfeng Tang
author_sort Fangfei Chen
collection DOAJ
description BackgroundMalaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world.ObjectiveThis study aimed to investigate China's malaria hospitalization costs and explore its determinants.MethodsStratified multistage sampling across provincial, municipal, and county hospitals was conducted in 2017. All the malaria medical records were retrieved from 2014 to 2016 in 70 hospitals. Parametric and non-parametric methods were employed to estimate hospitalization costs, and the non-parametric bootstrap was used to compare hospitalization costs among sample areas and assessed the uncertainty of its differences. Quantile regressions were conducted to identify the determinants of hospitalization costs.ResultsThe median hospitalization costs of 1633 malaria inpatients were 628 USD. Medication and laboratory tests accounted for over 70% of total expenditure. The median reimbursement rate was 41.87%, and this number was even lower in higher-level hospitals (<35%) and among the New Rural Cooperative Medical Scheme (<40%). Finally, health insurance type, hospital tier, clinical units, unknown fever, and comorbidity were the main determinants of hospitalization costs.ConclusionThe disparity of health protection for malaria hospitalization between rural and urban areas was noteworthy. Equivocal diagnosis and comorbidity are contributors of high cost as well. A reasonable payment system and enhanced capacities to treat malaria in a cost-effective way are suggested to reassure malaria economic burden.
first_indexed 2024-04-12T14:52:42Z
format Article
id doaj.art-95dd3d8ceb4240c59e4696fff1058983
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T14:52:42Z
publishDate 2022-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-95dd3d8ceb4240c59e4696fff10589832022-12-22T03:28:22ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-10-011010.3389/fpubh.2022.994529994529The economic burden of malaria inpatients and its determinants during China's elimination stageFangfei Chen0Xiaoyu Chen1Peng Gu2Xiaodong Sang3Ruijun Wu4Miaomiao Tian5Yisheng Ye6Chengxu Long7Ghose Bishwajit8Lu Ji9Da Feng10Lei Yang11Shangfeng Tang12School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaSchool of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaDivision of Comprehensive, China Science and Technology Exchange Center, Beijing, ChinaDivision of Comprehensive and Supervision, China Biotechnology Development Center, Beijing, ChinaDivision of Strategy and Policy, China Biotechnology Development Center, Beijing, ChinaDivision of Public Rights Protection, Beijing Municipal Health Commission, Beijing, ChinaSchool of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaFaculty of Social Science and Public Policy, King's College, London, United KingdomSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaSchool of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaSchool of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCollege of Public Administration, Huazhong University of Science and Technology, Wuhan, ChinaSchool of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, ChinaBackgroundMalaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world.ObjectiveThis study aimed to investigate China's malaria hospitalization costs and explore its determinants.MethodsStratified multistage sampling across provincial, municipal, and county hospitals was conducted in 2017. All the malaria medical records were retrieved from 2014 to 2016 in 70 hospitals. Parametric and non-parametric methods were employed to estimate hospitalization costs, and the non-parametric bootstrap was used to compare hospitalization costs among sample areas and assessed the uncertainty of its differences. Quantile regressions were conducted to identify the determinants of hospitalization costs.ResultsThe median hospitalization costs of 1633 malaria inpatients were 628 USD. Medication and laboratory tests accounted for over 70% of total expenditure. The median reimbursement rate was 41.87%, and this number was even lower in higher-level hospitals (<35%) and among the New Rural Cooperative Medical Scheme (<40%). Finally, health insurance type, hospital tier, clinical units, unknown fever, and comorbidity were the main determinants of hospitalization costs.ConclusionThe disparity of health protection for malaria hospitalization between rural and urban areas was noteworthy. Equivocal diagnosis and comorbidity are contributors of high cost as well. A reasonable payment system and enhanced capacities to treat malaria in a cost-effective way are suggested to reassure malaria economic burden.https://www.frontiersin.org/articles/10.3389/fpubh.2022.994529/fullhospitalization costsdisparitydeterminantsmalariaburden
spellingShingle Fangfei Chen
Xiaoyu Chen
Peng Gu
Xiaodong Sang
Ruijun Wu
Miaomiao Tian
Yisheng Ye
Chengxu Long
Ghose Bishwajit
Lu Ji
Da Feng
Lei Yang
Shangfeng Tang
The economic burden of malaria inpatients and its determinants during China's elimination stage
Frontiers in Public Health
hospitalization costs
disparity
determinants
malaria
burden
title The economic burden of malaria inpatients and its determinants during China's elimination stage
title_full The economic burden of malaria inpatients and its determinants during China's elimination stage
title_fullStr The economic burden of malaria inpatients and its determinants during China's elimination stage
title_full_unstemmed The economic burden of malaria inpatients and its determinants during China's elimination stage
title_short The economic burden of malaria inpatients and its determinants during China's elimination stage
title_sort economic burden of malaria inpatients and its determinants during china s elimination stage
topic hospitalization costs
disparity
determinants
malaria
burden
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.994529/full
work_keys_str_mv AT fangfeichen theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT xiaoyuchen theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT penggu theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT xiaodongsang theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT ruijunwu theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT miaomiaotian theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT yishengye theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT chengxulong theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT ghosebishwajit theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT luji theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT dafeng theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT leiyang theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT shangfengtang theeconomicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT fangfeichen economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT xiaoyuchen economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT penggu economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT xiaodongsang economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT ruijunwu economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT miaomiaotian economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT yishengye economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT chengxulong economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT ghosebishwajit economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT luji economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT dafeng economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT leiyang economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage
AT shangfengtang economicburdenofmalariainpatientsanditsdeterminantsduringchinaseliminationstage